Genetics Institute, LLC
Genetics Institute, LLC, a leading player in the biotechnology sector, is headquartered in the United States and operates across major regions including North America and Europe. Founded in 2005, the institute has made significant strides in genetic research and personalised medicine, establishing itself as a pioneer in the field.
The company specialises in advanced genomic sequencing and analysis, offering unique services that cater to both clinical and research applications. Its innovative approach to genetic testing and data interpretation sets it apart from competitors, ensuring high accuracy and reliability.
With a strong market position, Genetics Institute, LLC has achieved notable milestones, including partnerships with renowned research institutions and contributions to groundbreaking studies in genomics. The institute continues to drive advancements in genetic technology, making a lasting impact on healthcare and scientific research.
+44 vs industry average
Genetics Institute, LLC’s score of 82 is higher than 91% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Genetics Institute, LLC?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Reported emissions
No reported emissions data is available for Genetics Institute, LLC yet.
Genetics Institute, LLC's reported carbon emissions
Genetics Institute, LLC, headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Pfizer Inc., which means that any relevant emissions data or climate commitments may be inherited from its parent organisation.
As part of its corporate family relationship with Pfizer Inc., Genetics Institute, LLC aligns with the climate initiatives and targets set by Pfizer. This includes commitments to the Science Based Targets initiative (SBTi), the Carbon Disclosure Project (CDP), and the RE100 initiative, all of which are cascaded from Pfizer Inc. at a first-level relationship. However, specific reduction targets or achievements for Genetics Institute, LLC have not been detailed.
While no direct emissions data is available, the overarching commitment to sustainability and climate action is evident through its affiliation with Pfizer, which actively engages in reducing its carbon footprint and addressing climate change.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Genetics Institute, LLC’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Genetics Institute, LLC yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives

Science Based Targets Initiative
Inherited from Pfizer Inc.
Carbon Disclosure Project
Inherited from Pfizer Inc.The Climate Pledge
UN Global Compact Climate Champions initiative
Inherited from Pfizer Inc.RE 100
Inherited from Pfizer Inc.Climate Action 100
Emissions comparison with industry peers
View similar organisationsNo peer comparison is available for Genetics Institute, LLC yet.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project